New FDA-approved Therapeutic Improves Survival for Patients With Liposarcoma
Late last week, the U.S. Food and Drug Administration (FDA) approved a new treatment for one of the most...
Late last week, the U.S. Food and Drug Administration (FDA) approved a new treatment for one of the most...
Last year saw significant progress against lung cancer, with seven new therapeutics, including two immunotherapeutics, approved by the U.S....
This year has been a momentous year in healthcare, and, as some news outlets like Boston’s WBUR radio are...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new anticancer therapeutics continued last week when...
On Monday, the U.S. Food and Drug Administration (FDA) rounded out an exciting month for the multiple myeloma community...
As lung cancer awareness month drew to a close, the U.S. Food and Drug Administration (FDA) added another therapeutic...
Guest post by Roy S. Herbst, MD, PhD Yale Comprehensive Cancer Center
On Monday, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the immunotherapeutic...
The flurry of decisions from the U.S. Food and Drug Administration (FDA) on investigational anticancer therapeutics continued last week...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the lung cancer community during...